Overview

Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of once-daily and twice-daily celecoxib versus diclofenac for the treatment of ankylosing spondylitis
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Celecoxib
Diclofenac